Genetic and environmental aspect of polycystic ovary syndrome

被引:41
作者
Carmina, E [1 ]
机构
[1] Univ Palermo, Dipartimento Med Clin, Cattedra Endocrinol, I-90139 Palermo, Italy
关键词
PCOS; hyperandrogenism; insulin resistance; obesity;
D O I
10.1007/BF03345266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome determined in most patients by the association of two main factors: hyperandrogenism and insulin resistance. These characters are probably independent of each other and seem to be inherited by several different mechanisms. In some patients homozygous gene alteration has been found but in most patients PCOS seems to be determined by the association of gene polymorphisms that are common in the general population but alone are unable to determine phenotypic consequences. Alteration of genes that regulate the initial steps of ovarian steroidogenesis is probably the main causal factor of hyperandrogenism. Insulin resistance may be the result of many different gene alterations including insulin receptor substrate (IRS)-1 and 2, calpain-10 and peroxisome proliferator-activated receptor gamma(PPARgamma). Some polymorphisms may be protective against other gene alterations. Insulin sensitivity is also modified by socioeconomic and cultural factors that influence quantity and quality of food and energy expenditure. However, even eating behavior and weight response to food intake may be under genetic regulation. Different combinations of multiple gene polymorphisms and of environmental factors explain the heterogeneity of PCOS. (C) 2003, Editrice Kurtis.
引用
收藏
页码:1151 / 1159
页数:9
相关论文
共 83 条
[1]   Developmental origin of polycystic ovary syndrome - a hypothesis [J].
Abbott, DH ;
Dumesic, DA ;
Franks, S .
JOURNAL OF ENDOCRINOLOGY, 2002, 174 (01) :1-5
[2]  
ABBOTT DH, 1977, ANDROGEN EXCESS DISO, P369
[3]   A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[4]   Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J].
Azziz, R ;
Ehrmann, D ;
Legro, RS ;
Whitcomb, RW ;
Hanley, R ;
Fereshetian, AG ;
O'Keefe, M ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1626-1632
[5]  
Azziz R, 2000, J PEDIATR ENDOCR MET, V13, P1303
[6]   INSULIN STIMULATES ANDROGEN ACCUMULATION IN INCUBATIONS OF OVARIAN STROMA OBTAINED FROM WOMEN WITH HYPERANDROGENISM [J].
BARBIERI, RL ;
MAKRIS, A ;
RANDALL, RW ;
DANIELS, G ;
KISTNER, RW ;
RYAN, KJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :904-910
[7]   Association of insulin gene VNTR polymorphism with polycystic ovary syndrome - Reply [J].
Bennett, ST ;
Todd, JA ;
Waterworth, DM ;
Franks, S ;
McCarthy, MI .
LANCET, 1997, 349 (9067) :1771-1772
[8]   Genetics of obesity and type 2 diabetes -: Tracking pathogenic traits during the predisease period [J].
Bougnères, P .
DIABETES, 2002, 51 :S295-S303
[9]   Calpain: A protease in search of a function? [J].
Carafoli, E ;
Molinari, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (02) :193-203
[10]   EVIDENCE FOR A SINGLE GENE EFFECT CAUSING POLYCYSTIC OVARIES AND MALE PATTERN BALDNESS [J].
CAREY, AH ;
CHAN, KL ;
SHORT, F ;
WHITE, D ;
WILLIAMSON, R ;
FRANKS, S .
CLINICAL ENDOCRINOLOGY, 1993, 38 (06) :653-658